VectivBio Holding AG

NASDAQ: VECT · Real-Time Price · USD
16.87
0.02 (0.12%)
At close: Jul 07, 2023, 9:59 PM

VectivBio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
676K n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a
Gross Profit
676K n/a n/a n/a n/a
Operating Income
-28.55M -21.73M -21.73M -21.73M -21.73M
Interest Income
n/a n/a n/a n/a n/a
Pretax Income
-28.53M -21.74M -21.74M -21.74M -21.74M
Net Income
-28.48M -21.75M -21.75M -21.75M -21.75M
Selling & General & Admin
7.06M 8.95M 8.95M 8.95M 8.95M
Research & Development
-111.59M 12.54M 12.54M 12.54M 12.54M
Other Expenses
64.49M -43.22M -43.22M -43.22M -43.22M
Operating Expenses
-40.04M -21.73M -21.73M -21.73M -21.73M
Interest Expense
-27K 9K 9K 9K 9K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
-40.04M 21.68M 21.68M 21.68M 21.68M
Income Tax Expense
-48K 16K 16K 16K 16K
Shares Outstanding (Basic)
44.13M 26.96M 26.96M 26.96M 26.96M
Shares Outstanding (Diluted)
44.13M 26.96M 26.96M 26.96M 26.96M
EPS (Basic)
-0.65 -0.81 -0.81 -0.81 -0.81
EPS (Diluted)
-0.65 -0.81 -0.81 -0.81 -0.81
EBITDA
-28.64M -21.7M -21.7M -21.7M -21.7M
EBIT
-28.55M -21.73M -21.73M -21.73M -21.73M
Depreciation & Amortization
-87.75K 29.25K 29.25K 29.25K 29.25K